Ongoing CE Activities

36th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series

A Multidisciplinary Approach to Individualized Patient Care-Breast Cancer

Adipose Fat Distribution a CVD Risk After Breast Cancer

Breast Cancer: Genetic Testing and Management

Breast Cancer Prevention, Screening, Diagnosis, and Treatment

Breast Cancer Update, Issue 3, 2019: ER-Positive Edition

Breast Cancer Update: Triple-Negative Edition

Bridging the Gap between Research and Patient Care

Cancer Summaries and Commentaries™: Update from Barcelona: Advances in the Treatment of Breast Cancer

Challenges With the 8th Edition of the AJCC Staging Manual - Staging of Breast Cancer

Changing Landscape of Treatment of HR+ and HER2- Metastatic Breast Cancer with PI3K and CDK 4/6 Inhibitors

Community Practice Connections™: 1st Annual Precision Medicine Symposium: An Illustrated Tumor Board

Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™

Community Practice Connections™: Curbing the Opioid Epidemic: Taking Steps to Improve Postsurgical Outcomes for Your Patients With Breast Cancer

Community Practice Connections™: The Latest Advances on PI3K Inhibition in Breast Cancer: What You Need to Know

Current and Future Directions in PARP Inhibition

Data + Perspectives: Clinical Investigators Explore the Current and Future Management of Triple-Negative Breast Cancer

Denosumab Does Not Alter the Course of Early Breast Cancer

Elevated Breast Cancer Risk With HRT Persists

Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy

Empowering Oncology Teams to Improve Care Quality for Women with Advanced or Metastatic HR+/HER2- Breast Cancer

ER-Negative/PR-Positive Breast Cancer: Real or Artifact?

Evidence-based Integrative Therapies in Breast Cancer

Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments

Genetic/Familial High-Risk Evaluation in Patients With Breast Cancer

Herceptin: 6 or 12 Months?

Breast Cancer: Higher Progesterone Levels Tied to Increased Risk in Postmenopausal Women

High-Risk Multigene Testing Cost-Effective for Breast Cancer

HR+/HER2-Negative Breast Cancer: Revolutions in Precision Medicine with PI3K Inhibitors

Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging

Improving Outcomes in HER2+ Early Breast Cancer

Improving Outcomes in HER2+ Breast Cancer: Analysis and Application of Evolving Data and Best Practices

Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer

Interval Breast Cancer Increases Risk of Other Cancers

Locoregional Treatment of Breast Cancer Including SABCS Updates

Management of Lymphedema After Breast Cancer Treatment

Community Practice Connections™: Meeting Key Unmet Clinical Needs in HER2-Positive Breast Cancer: Aligning the Data with Strategy to Improve Patient Outcomes

NCCN GUIDELINES® UPDATES: Breast Cancer- Multigene Testing in Breast Cancer

Navigating the Rapidly Evolving Treatment Landscape for HER2+ Metastatic Breast Cancer

NCCN 2020 Congress Series: Breast Cancer With Updates From 2019 San Antonio Breast Cancer Symposium

NCCN GUIDELINES® INSIGHTS - GENETIC/FAMILIAL HIGH-RISK ASSESSMENT: BREAST, OVARIAN, AND PANCREATIC, VERSION 1.2020

NCCN Guidelines Update: Treatment of Hormone-Sensitive Advanced Breast Cancer

NCCN Harmonized Guidelines for Sub-Saharan Africa

Neoadjuvant & Adjuvant Therapies for Early Stage Breast Cancer

New Agents and Strategies in the Management of Breast Cancer — Part 3, Practical Integration of PARP Inhibitors

New and Emerging Treatment Options for Refractory HER2+ Metastatic Breast Cancer

New Systemic Therapies for Metastatic Breast Cancer Including SABCS Updates

PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application & Genetic Testing

Prioritizing Women With Dense Breasts for Supplemental Imaging

Proceedings from the First Annual Oncology Nursing Retreat ER-Positive Metastatic Breast Cancer

Proceedings from the First Annual Oncology Nursing Retreat HER2-Positive and Triple-Negative BC

Proton-Beam RT Proves Safe, Effective in Breast Cancer

Rapid Reviews in Oncology® from Chicago: Practice-Changing Data in Breast Cancer

Real-World Strategies to Transform a Triple-Negative Breast Cancer Diagnosis Into Positive Patient Outcomes

Recognition and Intervention for Women With Fluid That Develops Around Breast Implants

NCCN Updates in the treatment of HER-2 Positive Breast Cancer

Enduring CME Activity: School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?

The Jackson Laboratory Genetic Testing for Breast Cancer

The New Backbone of Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer - Animated Whiteboard View

The Role of Lifestyle and the Environment in Breast Cancer Risk

TNBC: Improvements Gained With PD-1/L1 Inhibitors

Use of Genomic Classifiers to Inform Clinical Decision-Making for Patients with Early Breast Cancer

Utility of MultiGene Assays in Management of Early Stage Breast Cancer

When Should Women With a Family History of Breast Cancer Start Screening?

Would Older Women With Breast Cancer Derive Benefits From Genetic Testing?